| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10970529 | Vaccine | 2007 | 5 Pages |
Abstract
PCV7 revaccination is safe and immunogenic in asplenic children previously vaccinated with PSV23, and could provide appropriate booster response in this high-risk population. The clinical repercussion on invasive pneumococcal diseases remains to be demonstrated.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
F. Smets, A. Bourgois, C. Vermylen, B. Brichard, P. Slacmuylders, S. Leyman, E. Sokal,